Tiago Biachi, Clinical Research Medical Director in the GI Oncology Department at Moffitt Cancer Center, shared on X:
“Portfolio update!
Look at the list of trials available at Moffitt Cancer Center right now or coming soon (*< 6 months) below.
Activating now: LiGeR-CRC2, global phase 3 trial using chemo/petosentamab vs chemo/cetux or bev in second line colorectal cancer BRAF/RAS wt.
Feel free to reach out here or at GIClinicalTrialReferrals@moffitt.org for referrals.”
You can also read: ECLYPse at ESMO 2026: Encorafenib + Cetuximab Beyond Progression With FOLFIRI in BRAF V600E mCRC
